Elana S Erhlich

Title: Elana S. Erhlich: Innovator in Lentiviral Research

Introduction

Elana S. Erhlich is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of virology, particularly in the study of lentiviruses. Her innovative work focuses on methods to inhibit the infectivity of these viruses, which are known to pose serious health risks.

Latest Patents

Elana holds a patent titled "Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity." This invention relates to a method for inhibiting the infectivity of lentiviruses, such as SIV, SHIV, and HIV. The method involves contacting a cell producing the virus with an antiviral-effective amount of a membrane-permeable zinc (Zn) chelator. Importantly, this amount does not substantially inhibit other Zn-binding proteins in the cell. The patent also includes kits and pharmaceutical compositions, as well as a method for identifying inhibitors of lentiviruses that target a specific zinc-binding motif of the lentivirus Vif protein. Elana has 1 patent to her name.

Career Highlights

Elana is affiliated with The Johns Hopkins University, where she continues her research and development in the field of virology. Her work has garnered attention for its potential applications in treating viral infections.

Collaborations

Elana has collaborated with notable colleagues, including Xiao-Fang Yu and Xiao Zuoxiang. These partnerships have contributed to the advancement of her research and the development of innovative solutions in the field.

Conclusion

Elana S. Erhlich is a dedicated inventor whose work in lentiviral research has the potential to impact public health significantly. Her innovative methods and collaborations highlight her commitment to advancing scientific knowledge and developing effective treatments.